By the time a compound or device enters pivotal trials, much market assessment has been done. What does ParagonRx add?

Using our ethnographic research methodology, we examine the market through the eyes of clinicians and patients who perceive therapy as a balance of benefit and risk. Our research provides insights into the barriers and drivers to prescribing and what clinicians and patients need to feel more confident about using your product.  The program we develop is for your product alone -- to address the gap between its theoretical rationale and use in practice.

We assess potential benefit at any life cycle stage by leveraging your own clinical studies and research, including advisory boards.

The research is documented in a CareMap™ that synthesizes the findings observed in clinical practice.

 

 
Register for periodic industry updates: